Last reviewed · How we verify
NCT03569306
ENB in the Diagnosis of Peripheral Pulmonary Nodules
NA trial testing ENB in Peripheral Pulmonary Nodules in 400 participants. Status unknown.
30 December 2019
Quick facts
| Lead sponsor | Shanghai Chest Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 400 |
| Start date | 4 July 2018 |
| Primary completion | 30 December 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- ENB
- EBUS-GS
Conditions studied
- Peripheral Pulmonary Nodules — all drugs for Peripheral Pulmonary Nodules →
Sponsor
Shanghai Chest Hospital
Who can join
18 and older, any sex, with Peripheral Pulmonary Nodules. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is designed as a multi-center prospective trial with two arms, ENB-EBUS-GS group and EBUS-GS group, and aimed to evaluate the diagnostic yield and operation time between the two groups.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Novel Electromagnetic Navigation Bronchoscopy System for the Diagnosis of Peripheral Pulmonary Nodules: A Randomized Clinical Trial.
Zheng X, Cao L, Zhang Y, Xie F, et al · · 2022 · cited 17× · PMID 35679184 · DOI 10.1513/annalsats.202109-1071oc -
Design of a prospective, multicenter, and cohort study of an innovative electromagnetic navigation bronchoscopy in diagnosing pulmonary nodules among Chinese population.
Xie F, Zhang J, Cao L, Zheng X, et al · · 2019 · cited 6× · PMID 32030279 · DOI 10.21037/jtd.2019.11.75
Verify or expand the search:
- PubMed search for NCT03569306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ENB
Trials testing the same drug.
- NCT06741267 — The Assessment of the Feasibility and Operational Performance of Automated System Bronchoscopy in a Simulated Environmen · NA · unknown
- NCT04553809 — Navigation Endobronchial Ultrasound · NA · completed
Other Shanghai Chest Hospital trials
Trials by the same sponsor.
- NCT07515027 — Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung · NA · recruiting
- NCT07479628 — Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma · Phase 2 · not yet recruiting
- NCT07528066 — Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC · recruiting
- NCT07331727 — Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation · NA · not yet recruiting
- NCT07320768 — Renal Denervation Combined With Pulsed Field Ablation to Prevent Blanking-Period Recurrence in Persistent Atrial Fibrill · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03569306 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Chest Hospital
- Last refreshed: 6 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03569306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing